House Dems Target Exclusivity, Pricing Of COVID-19 Drugs
A group of senior House Democrats on Wednesday outlined their approach to pricing coronavirus-related pharmaceuticals with a ban on exclusivity, a requirement of reasonable prices and transparent corporate reporting on expenses....To view the full article, register now.
Already a subscriber? Click here to view full article